Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
NCT00086164 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2005-07-19
Summary
The purpose of this study is to determine the effect of recipient vein pretreatment of edifoligide (E2F Decoy), compared to placebo, on graft/recipient vein stenosis in polytetrafluoroethylene (PTFE) vascular access grafts placed for hemodialysis at 6 months after enrollment.
Conditions
- Hyperplasia
- Chronic Renal Failure
Interventions
- DRUG
-
edifoligide (E2F Decoy)
Sponsors & Collaborators
-
Anesiva, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients
NCT03523728 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
NCT02335099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
NCT03062176 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis
NCT05213624 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
NCT00721422 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis
NCT01147666 ·Status: COMPLETED ·Phase: PHASE2
-
Primovist / Eovist in Renally Impaired Patients
NCT00908596 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population
NCT02486744 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
NCT05927415 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)
NCT06602453 ·Status: TERMINATED ·Phase: PHASE2
-
Mitigation of Radiation Pneumonitis and Fibrosis
NCT01754909 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT04578548 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
NCT00293202 ·Status: TERMINATED ·Phase: PHASE2
-
Sirolimus Use in Angioplasty for Vascular Access Extension
NCT01595841 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3113593 in Participants With Chronic Kidney Disease
NCT02604160 ·Status: COMPLETED ·Phase: PHASE1
-
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
NCT00843349 ·Status: COMPLETED ·Phase: NA
-
Prospective, Multicenter, Non-randomized, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of e-PTFE Grafts Inner Surface-treated With Paclitaxel as an Access for Hemodialysis in Patients With End-stage Renal Disease.
NCT04285073 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
NCT05810961 ·Status: TERMINATED ·Phase: PHASE2
-
Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
NCT01503021 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
NCT07020832 ·Status: RECRUITING ·Phase: PHASE3
-
Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin
NCT05031546 ·Status: APPROVED_FOR_MARKETING
-
A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
NCT00312767 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
NCT03289520 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)
NCT03448692 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II
NCT05055258 ·Status: TERMINATED ·Phase: PHASE2